A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)

Turner, Nicholas C.; Telli, Melinda L.; Rugo, Hope S.; Mailliez, Audrey; Ettl, Johannes; Grischke, Eva-Maria; Mina, Lida A.; Balmana, Judith; Fasching, Peter A.; Hurvitz, Sara A.; Wardley, Andrew M.; Chappey, Colombe; Hannah, Alison L.; Robson, Mark E.

Publikationsdienste
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
Dokumentanzeige

« zurück

A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)

Autor(en):

Turner, Nicholas C.; Telli, Melinda L.; Rugo, Hope S.; Mailliez, Audrey; Ettl, Johannes; Grischke, Eva-Maria; Mina, Lida A.; Balmana, Judith; Fasching, Peter A.; Hurvitz, Sara A.; Wardley, Andrew M.; Chappey, Colombe; Hannah, Alison L.; Robson, Mark E.

Tübinger Autor(en):

Grischke, Eva-Maria

Erschienen in:

Clinical Cancer Research (2019), Bd. 25, H. 9, S. 2717-2724

Verlagsangabe:

Amer Assoc Cancer Research

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1158/1078-0432.CCR-18-1891

ISSN:

1557-3265